UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063719
Receipt number R000071424
Scientific Title A survey on the actual clinical practice of hyperkalemia in tertiary emergency hospitals
Date of disclosure of the study information 2026/11/21
Last modified on 2026/11/21 14:20:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A survey on the actual clinical practice of hyperkalemia in tertiary emergency hospitals

Acronym

A survey on the actual clinical practice of hyperkalemia in tertiary emergency hospitals

Scientific Title

A survey on the actual clinical practice of hyperkalemia in tertiary emergency hospitals

Scientific Title:Acronym

A survey on the actual clinical practice of hyperkalemia in tertiary emergency hospitals

Region

Japan


Condition

Condition

Hyperkalemia

Classification by specialty

Nephrology Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the actual treatment status of hyperkalemia at Hitachi General Hospital and clarify the prevalence, patient characteristics, treatments, and outcomes of hyperkalemia.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Admission, kidnet replacement therapy, survival

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

Outpatients who visited Hitachi General Hospital and underwent blood collection and serum potassium measurement between April 2018 and May 2024.

Key exclusion criteria

1. Patients who opt out of this study based on the clinical research explanation posted on our hospital's website.
2. Patients who are cardiopulmonary arrest upon arrival.
3. Patients on maintenance dialysis (hemodialysis or peritoneal dialysis) and post-renal transplant patients.
4. Other patients judged by the principal investigator to be inappropriate as study participants.

Target sample size

40000


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Nagai

Organization

Hitachi General Hospital

Division name

Department of Nephrology

Zip code

317-0077

Address

Jonan-cho 2-1-1, Hitachi, Ibaraki

TEL

0294231111

Email

knagai@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name Kei
Middle name
Last name Nagai

Organization

Hitachi General Hospital

Division name

Department of Nephrology

Zip code

317-0077

Address

Jonan-cho 2-1-1, Hitachi, Ibaraki

TEL

0294231111

Homepage URL


Email

knagai@md.tsukuba.ac.jp


Sponsor or person

Institute

Others

Institute

Department

Personal name



Funding Source

Organization

JSPS

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hitachi General Hospital

Address

Jonan-cho 2-1-1, Hitachi, Ibaraki

Tel

0294231111

Email

knagai@md.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 21 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

65236

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 06 Month 24 Day

Date of IRB

2024 Year 06 Month 24 Day

Anticipated trial start date

2024 Year 06 Month 24 Day

Last follow-up date

2026 Year 11 Month 21 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study in the single center


Management information

Registered date

2026 Year 11 Month 21 Day

Last modified on

2026 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071424